Search results
Results from the WOW.Com Content Network
Normal - recognizes people and generally knows who they are. Usually recognizes grandchildren, cousins or relatives who are not seen frequently but may not recall how they are related. Usually does not recognize family members who are not seen frequently.
The Clinical Dementia Rating (CDR) Scale stages dementia, including Alzheimer’s, in elderly patients.
These cognitive assessment tools are used to identify individuals who may need additional evaluation. No one tool is recognized as the best brief assessment to determine if a full dementia evaluation is needed.
The Dementia Rating Scale (DRS) is a widely used measure of global cognition, with age- and education-corrected norms derived from a cross-sectional sample of adults participating in Mayo's Older Americans Normative Studies (MOANS).
The Dementia Rating Scale (DRS) is considered a very useful instrument to assess patients with dementia. The tasks are grouped into five subscales, each one evaluating different cognitive areas, namely: Attention, Initiation/Perseveration (I/P), Construction, Conceptualization and Memory.
The Dementia Rating Scale-2 (DRS-2) is the most recent edition (2001) of a battery-style assessment of mental status in older patients with suspected dementia.
The Dementia Severity Rating Scale (DSRS) is a brief informant-rated, multiple-choice questionnaire made up of 12-items that measure functional abilities and parallel CDR content 7. The DSRS requires minimal staff training to administer, takes five minutes to complete, and can be completed via mail, Internet, or phone.
The DRS-2 assesses a patient’s overall level of cognitive functioning. Used to track changes in cognitive status over time. Two forms allow for a better characterization of declining cognitive status and an improvement in the evaluation of treatment efficacy.
What is the Clinical Dementia Rating (CDR) scale . Scoring and interpretation . How does CDR compare with other commonly used clinical tools? . 4. 5. 6. 8. 10. The design of clinical studies in Alzheimer’s disease (AD) largely depends on the clinical stage. Clinical endpoints for early stage AD.
Assessment scales in the domains of cognition, function, behaviour, quality of life, depression in dementia, carer burden and overall dementia severity are reviewed in this article. The practical use of these scales in clinical practice and in research is discussed.